OBJECTIVES: The aim was to perform a genetically detailed study of the emergence of metallo-beta-lactamase (MBL) genes in Pseudomonas spp. in the Children's Memorial Health Institute over a 9 year period. METHODS: Carbapenem-resistant Pseudomonas spp. isolates were collected from 1998 to 2006 and screened for MBL production. MBL-positive isolates were further investigated by a combination of genetic techniques including PCR, genomic location experiments using pulsed-field gel electrophoresis (PFGE) of I-Ceu1, S1 and SpeI digests, and sequencing. RESULTS: Of the 20 MBL-containing Pseudomonas isolates collected from 1998 to 2006, 16 Pseudomonas aeruginosa isolates contained an identical class 1 integron structure. Two P. aeruginosa isolates contained the bla(VIM-2) gene, and two Pseudomonas putida isolates harboured the bla(VIM-4) gene cassette in different integron structures. PFGE analysis indicated that all bla(VIM-4)-containing P. aeruginosa isolates were closely related, whereas the P. putida isolates were not. All MBL genes in this study were chromosomally encoded, and all isolates harboured only one class 1 integron. The bla(VIM-2) isolates were clonal, and the genetic structure supporting the bla(VIM-2) gene was found in an identical chromosomal position. CONCLUSIONS: MBL gene emergence in this hospital has paralleled a 6-fold increase in carbapenem usage. We have found an increase in MBL gene diversity, MBL host organisms and MBL genetic support structures in the hospital over the 9 year study period. There is also compelling evidence of the persistence of individual strains in the hospital throughout the study period. This suggests that once MBL genes have emerged in a hospital environment, they are difficult to remove.
OBJECTIVES: The aim was to perform a genetically detailed study of the emergence of metallo-beta-lactamase (MBL) genes in Pseudomonas spp. in the Children's Memorial Health Institute over a 9 year period. METHODS:Carbapenem-resistant Pseudomonas spp. isolates were collected from 1998 to 2006 and screened for MBL production. MBL-positive isolates were further investigated by a combination of genetic techniques including PCR, genomic location experiments using pulsed-field gel electrophoresis (PFGE) of I-Ceu1, S1 and SpeI digests, and sequencing. RESULTS: Of the 20 MBL-containing Pseudomonas isolates collected from 1998 to 2006, 16 Pseudomonas aeruginosa isolates contained an identical class 1 integron structure. Two P. aeruginosa isolates contained the bla(VIM-2) gene, and two Pseudomonas putida isolates harboured the bla(VIM-4) gene cassette in different integron structures. PFGE analysis indicated that all bla(VIM-4)-containing P. aeruginosa isolates were closely related, whereas the P. putida isolates were not. All MBL genes in this study were chromosomally encoded, and all isolates harboured only one class 1 integron. The bla(VIM-2) isolates were clonal, and the genetic structure supporting the bla(VIM-2) gene was found in an identical chromosomal position. CONCLUSIONS:MBL gene emergence in this hospital has paralleled a 6-fold increase in carbapenem usage. We have found an increase in MBL gene diversity, MBL host organisms and MBL genetic support structures in the hospital over the 9 year study period. There is also compelling evidence of the persistence of individual strains in the hospital throughout the study period. This suggests that once MBL genes have emerged in a hospital environment, they are difficult to remove.
Authors: Jaroslav Hrabák; Dana Cervená; Radoslaw Izdebski; Wojciech Duljasz; Marek Gniadkowski; Marta Fridrichová; Pavla Urbásková; Helena Zemlicková Journal: J Clin Microbiol Date: 2010-10-27 Impact factor: 5.948
Authors: Paweł Urbanowicz; Ibrahim Bitar; Radosław Izdebski; Anna Baraniak; Elżbieta Literacka; Jaroslav Hrabák; Marek Gniadkowski Journal: Antimicrob Agents Chemother Date: 2021-03-18 Impact factor: 5.191
Authors: Dongeun Yong; Mark A Toleman; Christian G Giske; Hyun S Cho; Kristina Sundman; Kyungwon Lee; Timothy R Walsh Journal: Antimicrob Agents Chemother Date: 2009-09-21 Impact factor: 5.191
Authors: Orjan Samuelsen; Mark A Toleman; Arnfinn Sundsfjord; Johan Rydberg; Truls M Leegaard; Mats Walder; Astrid Lia; Trond E Ranheim; Yashas Rajendra; Nils O Hermansen; Timothy R Walsh; Christian G Giske Journal: Antimicrob Agents Chemother Date: 2009-11-02 Impact factor: 5.191
Authors: Andreas F Wendel; Sofija Ressina; Susanne Kolbe-Busch; Klaus Pfeffer; Colin R MacKenzie Journal: Appl Environ Microbiol Date: 2016-05-31 Impact factor: 4.792
Authors: Andreas F Wendel; Alexander H B Brodner; Stephan Wydra; Sofija Ressina; Birgit Henrich; Klaus Pfeffer; Mark A Toleman; Colin R Mackenzie Journal: Antimicrob Agents Chemother Date: 2013-07-22 Impact factor: 5.191